Nephrology

More than 1 in 7 adults in the United States are living with chronic kidney disease, with up to 90% unaware that they have the disease, and over 800,000 people living with end-stage disease. Drug development in nephrology offers hope, with a focus on targeted treatments that modify the disease trajectory as opposed to providing supportive care.